Notice2022-12901
Foreign-Trade Zone (FTZ) 61-San Juan, Puerto Rico; Notification of Proposed Production Activity; Boehringer Ingelheim Animal Health Puerto Rico LLC (Pharmaceutical Products/Canine); Barceloneta, Puerto Rico
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 15, 2022
Issuing agencies
Commerce DepartmentForeign-Trade Zones Board
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 115 (Wednesday, June 15, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 115 (Wednesday, June 15, 2022)]
[Notices]
[Pages 36103-36104]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-12901]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-24-2022]
Foreign-Trade Zone (FTZ) 61--San Juan, Puerto Rico; Notification
of Proposed Production Activity; Boehringer Ingelheim Animal Health
Puerto Rico LLC (Pharmaceutical Products/Canine); Barceloneta, Puerto
Rico
Boehringer Ingelheim Animal Health Puerto Rico LLC (Boehringer
Ingelheim) submitted a notification of proposed production activity to
the FTZ Board (the Board) for its facility in Barceloneta, Puerto Rico
within FTZ 61. The notification conforming to the requirements of the
Board's regulations (15 CFR 400.22) was received on June 7, 2022.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status material(s)/component(s) and
specific finished product(s) described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via <a href="http://www.trade.gov/ftz">www.trade.gov/ftz</a>.
The proposed finished products include finished (packaged) and
semi-finished (unpackaged) antiparasitic chewable tablets for canines
(duty rate is duty-free).
The proposed foreign-status materials and components include
afoxolaner, milbemycin oxime, plastic film for packaging, and plastic
bags/pouches for packaging (duty rate ranges from 3.0 to 6.5%). The
request indicates that certain materials/components are subject to
duties under Section 301 of the Trade Act of 1974 (Section 301),
depending on the country of origin. The applicable Section 301
decisions require subject merchandise to be admitted to FTZs in
privileged foreign status (19 CFR 146.41).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
<a href="/cdn-cgi/l/email-protection#1670626c56626477727338717960"><span class="__cf_email__" data-cfemail="5d3b29271d292f3c3938733a322b">[email protected]</span></a>. The closing period for their receipt is July 25, 2022.
[[Page 36104]]
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Juanita Chen at
<a href="/cdn-cgi/l/email-protection#8de7f8ece3e4f9eca3eee5e8e3cdf9ffece9e8a3eae2fb"><span class="__cf_email__" data-cfemail="bad0cfdbd4d3cedb94d9d2dfd4facec8dbdedf94ddd5cc">[email protected]</span></a>.
Dated: June 9, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-12901 Filed 6-14-22; 8:45 am]
BILLING CODE 3510-DS-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 15, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.